Spring Bank Pharmaceuticals
Milford
About Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals is an IND-stage drug discovery company. Based on its proprietary platform technology, the company is developing a pipeline of products representing a new class of pharmaceuticals they call small molecule nucleic acid hybrids with a wide range of applications and multi-billion dollar market potential.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.0M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2015)
- Ticker: nasdaq:SBPH
- Website: springbankpharm.com
- Phone: +1 508-473-5993
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/spring-bank-pharmaceuticals-2233146 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.